Author

Corinne Emery

Observed names: C Emery, C. Emery, Corinne EMERY

Institution: Cemka-Eval (France)

Observed institution: Cemka-Eval (France)

ORCID: 0000-0002-7333-0567

Observed ORCID: 0000-0002-7333-0567

OpenAlex ID: A5036933320

Trends in the real-world management of patients with active relapsing-remitting multiple sclerosis treated with natalizumab (TYSABRI®) in France: An analysis of the PMSI database over five years (2019–2023)

2025 · E. Le Page, C. Emery, et al. · Revue Neurologique · 2

Economic burden of type 2 diabetes management in France according to clinical characteristics

2026 · Bruno Guerci, Christèle Blanc‐Bisson, et al. · Diabetes Obesity and Metabolism · 1

Medical code embeddings from claims-based co-occurrences: a unified semantic space for ICD-10 diagnoses and ATC medications

2026 · Corentin Faujour, Stéphane Bouée, et al. · Journal of the American Medical Informatics Association

Evaluating the Role of Order and Time Information for Classifying Sequences of Healthcare Events Derived from Claims Data

2026 · Corentin Faujour, Stéphane Bouee, et al. · Studies in health technology and informatics

Comparaison entre approches statistiques et réseaux de neurones pour identifier les patients en errance diagnostique à partir du Système National des Données de Santé.

2026 · Corentin FAUJOUR, Stéphane BOUEE, et al. · Journal of Epidemiology and Population Health

Évolution de la prise en charge des patients atteints de la sclérose en plaques rémittente-récurrente et traités par natalizumab (TYSABRI, forme intra-veineuse et sous-cutanée) en France : une analyse du PMSI sur la période 2019/2022

2024 · Agathe Doutriaux, Corinne Emery, et al. · Revue Neurologique

RWD123 Real-World Data About Treatment Pattern and Outcomes of Patients With Unresectable Advanced or Metastatic Esophageal Squamous Cell Carcinoma in France: Results From the Fregat Database

2022 · G Piessen, A Adenis, et al. · Value in Health

Works count: 7

Citation count: 3

H-index: 1

I10-index: